The Incidence and Detectability of Phlebitis by Healthcare Professional in a 1200 Bed Teaching Hospital

  • Print

Nabil Khalidi, PharmD, Wesam W. Ismail, MS, Rami Bustami, PhD, Razan ElMelik, PharmD, Salah Aburuz, PhD, Abdulkareem Albekairy, PharmD, Abdulmalik Alkatheri, PharmD, Omar Alzuwayed, PharmD, Nasser Almanei, PharmD, Feras Almogbel, PharmD  "The Incidence and Detectability of Phlebitis by Healthcare Professional in a 1200 Bed Teaching Hospital”   -International Journal of Nursing, Midwife and Health Related Cases, Vol.3, No.5, pp.1-10, November 2017 |Print ISSN: 2397-0758, Online ISSN: 2397-0766

 

Please click here to see the article.

 

Tracing the Epidemic History of Hepatitis C Virus Genotypes in Saudi Arabia

  • Print

Anis Khan, Mohammed Al Balwi, Latifah AlAyyar, Ibrahim AlAbdulkareem, Abdulkareem Albekairy, Abdulrahman Aljumah  "Tracing the Epidemic History of Hepatitis C Virus Genotypes in Saudi Arabia”  -Elsevier, Infection, Genetics and Evolution, 52 (2017) 82–88 |http://dx.doi.org/10.1016/j.meegid.2017.04.024

 

Please click here to see the article.

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab, and Aflibercept) for treatment of corneal neovascularization

  • Print

Tariq Al-Debasi; Abdulkareem Al-Bekairy; Abdulmalik Al-Katheri; Shmeylan Al Harbi; Mahmoud Mansour  "Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab, and Aflibercept) for treatment of corneal neovascularization”    -Saudi Journal of Ophthalmology (2017) 31, 99–105 |http://dx.doi.org/10.1016/j.sjopt.2017.02.008

 

Please click here to see the article.

Validation of HPLC-UV Method for Analysis of 4-Pyridoxic Acid in Human Urine

  • Print

Mohammad Shawaqfeh, Wenchen Zhao and Suhaib Muflih  "Validation of HPLC-UV Method for Analysis of 4-Pyridoxic Acid in Human Urine”   -International Journal of Medical Research & Health Sciences, 2017, 6(12): 100-104, ISSN No: 2319-5886

 

Please click here to see the article.

Optimization of a Nanostructured Lipid Carriers System for Enhancing the Biopharmaceutical Properties of Valsartan

  • Print

M. A. Albekery, K. T. Alharbi, S. Alarifi, D. Ahmad, M. E Omer, S. Massadeh, A. E. Yassin  "Optimization of a Nanostructured Lipid Carriers System for Enhancing the Biopharmaceutical Properties of Valsartan”   -Digest Journal of Nanomaterials and Biostructures, Vol. 12, No. 2, April - June 2017, p. 381 - 389

 

Please click here to see the article.

More Articles...

  1. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol1 gel under Dermaroller1 on rats with methyl prednisolone acetate-induced hypertension
  2. Effects of antirheumatic drug underutilization on rheumatoid arthritis disease activity
  3. Weekly therapeutic effectiveness of different doses of Eprex; Epoetin alfa® in the treatment of anemia of chronic kidney disease adult patients
  4. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil

College of Pharmacy - KSAU-HS © 2012 - 2022